Nasdaq [NDAQ] vs CME [CME] Detailed Stock Comparison
Nasdaq
NASDAQ
Loading...
CME
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Nasdaq wins in 6 metrics, CME wins in 14 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nasdaq | CME | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.42 | 26.52 | CME |
| Price-to-Book Ratio | 4.60 | 3.55 | CME |
| Debt-to-Equity Ratio | 81.98 | 13.60 | CME |
| PEG Ratio | 0.36 | 1.70 | Nasdaq |
| EV/EBITDA | 22.06 | 22.08 | Nasdaq |
| Profit Margin (TTM) | 18.59% | 58.59% | CME |
| Operating Margin (TTM) | 29.23% | 66.87% | CME |
| EBITDA Margin (TTM) | 29.23% | 66.87% | CME |
| Return on Equity | 13.25% | 13.61% | CME |
| Return on Assets (TTM) | 4.64% | 1.74% | Nasdaq |
| Free Cash Flow (TTM) | $1.73B | $3.60B | CME |
| Dividend Yield | 1.33% | 4.30% | CME |
| 1-Year Return | 33.38% | 31.12% | Nasdaq |
| Price-to-Sales Ratio (TTM) | 6.70 | 15.35 | Nasdaq |
| Enterprise Value | $63.28B | $100.39B | CME |
| EV/Revenue Ratio | 7.80 | 15.61 | Nasdaq |
| Gross Profit Margin (TTM) | 41.20% | 86.90% | CME |
| Revenue per Share (TTM) | $14 | $18 | CME |
| Earnings per Share (Diluted) | $2.60 | $10.33 | CME |
| Beta (Stock Volatility) | 1.01 | 0.46 | CME |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nasdaq vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nasdaq | 0.70% | -2.39% | 5.14% | 14.48% | 13.61% | 21.18% |
| CME | 1.10% | -1.59% | -1.28% | -2.32% | 8.27% | 16.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nasdaq | 33.38% | 54.61% | 113.49% | 446.79% | 1,418.28% | 1,123.34% |
| CME | 31.12% | 38.27% | 53.36% | 186.93% | 428.70% | 404.63% |
Performance & Financial Health Analysis: Nasdaq vs CME
| Metric | NDAQ | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $54.33B | $98.72B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,877,010 | 1,887,200 |
| 90 Day Avg. Volume | 3,334,527 | 2,111,473 |
| Last Close | $94.49 | $274.47 |
| 52 Week Range | $64.84 - $97.63 | $206.44 - $290.79 |
| % from 52W High | -3.22% | -5.61% |
| All-Time High | $97.63 (Aug 11, 2025) | $290.79 (Jun 02, 2025) |
| % from All-Time High | -3.22% | -5.61% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.10% |
| Quarterly Earnings Growth | 1.04% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.59% |
| Operating Margin (TTM) | 0.29% | 0.67% |
| Return on Equity (TTM) | 0.13% | 0.14% |
| Debt to Equity (MRQ) | 81.98 | 13.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $20.58 | $77.13 |
| Cash per Share (MRQ) | $1.30 | $5.82 |
| Operating Cash Flow (TTM) | $2.36B | $4.20B |
| Levered Free Cash Flow (TTM) | $1.90B | $2.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.33% | 4.30% |
| Last 12-Month Dividend | $1.26 | $11.85 |
Valuation & Enterprise Metrics Analysis: Nasdaq vs CME
| Metric | NDAQ | CME |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.42 | 26.52 |
| Forward P/E | 30.15 | 26.41 |
| PEG Ratio | 0.36 | 1.70 |
| Price to Sales (TTM) | 6.70 | 15.35 |
| Price to Book (MRQ) | 4.60 | 3.55 |
| Market Capitalization | ||
| Market Capitalization | $54.33B | $98.72B |
| Enterprise Value | $63.28B | $100.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.80 | 15.61 |
| Enterprise to EBITDA | 22.06 | 22.08 |
| Risk & Other Metrics | ||
| Beta | 1.01 | 0.46 |
| Book Value per Share (MRQ) | $20.58 | $77.13 |
Financial Statements Comparison: Nasdaq vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NDAQ | CME |
|---|---|---|
| Revenue/Sales | $2.09B | $1.64B |
| Cost of Goods Sold | $1.23B | $206.70M |
| Gross Profit | $861.00M | $1.44B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $597.00M | $1.11B |
| EBITDA | $788.00M | $476.30M |
| Pre-Tax Income | $548.00M | $1.24B |
| Income Tax | $96.00M | $288.60M |
| Net Income (Profit) | $452.00M | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NDAQ | CME |
|---|---|---|
| Cash & Equivalents | $690.00M | $1.41B |
| Total Current Assets | $7.82B | $123.45B |
| Total Current Liabilities | $7.97B | $121.42B |
| Long-Term Debt | $9.32B | $3.42B |
| Total Shareholders Equity | $11.56B | $27.03B |
| Retained Earnings | $8.66B | $4.69B |
| Property, Plant & Equipment | $1.00B | $371.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NDAQ | CME |
|---|---|---|
| Operating Cash Flow | $879.00M | $838.30M |
| Capital Expenditures | $-49.00M | $-14.20M |
| Free Cash Flow | $614.00M | $1.10B |
| Debt Repayment | $-257.00M | $-750.00M |
| Common Stock Repurchase | $-115.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NDAQ | CME |
|---|---|---|
| Shares Short | 5.36M | 5.42M |
| Short Ratio | 1.53 | 2.53 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 2,877,010 | 1,887,200 |
| Average Daily Volume (90 Day) | 3,334,527 | 2,111,473 |
| Shares Outstanding | 575.06M | 359.61M |
| Float Shares | 511.57M | 358.78M |
| % Held by Insiders | 0.11% | 0.00% |
| % Held by Institutions | 0.86% | 0.92% |
Dividend Analysis & Yield Comparison: Nasdaq vs CME
| Metric | NDAQ | CME |
|---|---|---|
| Last 12-Month Dividend | $1.26 | $11.85 |
| Last 12-Month Dividend Yield | 1.33% | 4.30% |
| 3-Year Avg Annual Dividend | $0.99 | $10.10 |
| 3-Year Avg Dividend Yield | 0.35% | 0.91% |
| 3-Year Total Dividends | $2.98 | $30.30 |
| Ex-Dividend Date | Sep 12, 2025 | Sep 09, 2025 |